Cowealth Medical Holding Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 11, 2021
Share
Cowealth Medical Holding Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 1,289.11 million compared to TWD 1,071.16 million a year ago. Net income was TWD 22.06 million compared to TWD 18.29 million a year ago. Basic earnings per share from continuing operations was TWD 0.28 compared to TWD 0.24 a year ago. Diluted earnings per share from continuing operations was TWD 0.28 compared to TWD 0.24 a year ago.
For the nine months, sales was TWD 3,881.18 million compared to TWD 3,260.15 million a year ago. Net income was TWD 90.56 million compared to TWD 121.51 million a year ago. Basic earnings per share from continuing operations was TWD 1.17 compared to TWD 1.57 a year ago. Diluted earnings per share from continuing operations was TWD 1.17 compared to TWD 1.57 a year ago.
Cowealth Medical Holding Co., Ltd. is a Cayman Islands-based holding company primarily engaged in the manufacture and distribution of medical devices and products. The Company's products include cancer treatment and medical testing equipment and reagents and supplies for clinical testing applications. The Company mainly distributes its products in China.